Artificial intelligence for biomarker prediction in gastric cancer: from histopathology to multimodal integration - Takeaways - MDSpire

Artificial intelligence for biomarker prediction in gastric cancer: from histopathology to multimodal integration

  • By

  • Yesul Jeong

  • Sangjeong Ahn

  • Sung Hak Lee

  • June 16, 2026

  • 0 min

Share

  • 1

    Gastric cancer exhibits significant molecular heterogeneity, necessitating precision oncology approaches for effective treatment.

  • 2

    AI-enabled computational pathology using whole-slide images offers a scalable method for biomarker assessment in gastric cancer.

  • 3

    AI models have shown promise in predicting microsatellite instability and Epstein-Barr virus status, aiding in biomarker triage.

  • 4

    Multimodal integration of histopathology with other data types enhances predictive performance for treatment responses and recurrence.

  • 5

    Challenges such as model interpretability and data variability must be addressed for successful clinical implementation of AI in pathology.

Original Source(s)

Artificial intelligence for biomarker prediction in gastric cancer: from histopathology to multimodal integration

  • by Yesul Jeong, Sangjeong Ahn, Sung Hak Lee

  • June 16, 2026

Related Content

Primary cutaneous adenoid cystic carcinoma of the right forearm: a case report and dermoscopic features

Correction: miR-17: from developmental regulatory hub to molecular engine driving tumourigenesis

L-arginine metabolism in breast cancer: mechanisms and therapeutic targets